Supernus Pharma (SUPN) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Supernus Pharma (SUPN) Tops Q4 EPS by 3c
March 10, 2015 5:00 PM EDT
Cash flow positive for the fourth quarter, $5.9 million, and for the full year, $3.2 million.
Â
Net income for the fourth quarter, $4.4 million, and for the full year, $19.9 million.
Â
Total revenue for the fourth quarter, $30.8 million, exceeded guidance by $4 million, and includes $30.5 million in net product sales.
Â
Total revenue for full year 2014 was $122.0 million, including $89.6 million in net product sales.
Â
Fourth quarter product prescriptions increased to 70,739, representing a 22% increase over the third quarter of 2014.
Â
Met with the FDA in December to review SPN-810. We remain on-track to initiate Phase III testing in the fourth quarter of... More
March 10, 2015 5:00 PM EDT
Cash flow positive for the fourth quarter, $5.9 million, and for the full year, $3.2 million.
Â
Net income for the fourth quarter, $4.4 million, and for the full year, $19.9 million.
Â
Total revenue for the fourth quarter, $30.8 million, exceeded guidance by $4 million, and includes $30.5 million in net product sales.
Â
Total revenue for full year 2014 was $122.0 million, including $89.6 million in net product sales.
Â
Fourth quarter product prescriptions increased to 70,739, representing a 22% increase over the third quarter of 2014.
Â
Met with the FDA in December to review SPN-810. We remain on-track to initiate Phase III testing in the fourth quarter of... More
